Atlas Trials

Study of NG-641 in Combination With Nivolumab in Metastatic or Advanced Epithelial Tumours

Clinical trial NCT05043714 · COMPLETED

Trial details

NCT number
NCT05043714
Sponsor
Akamis Bio
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic CancerEpithelial Tumor
Start date
2021-12-01
Primary completion
2023-11-13
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.